Targeted disruption of T cell receptor genes using talens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9937207
SERIAL NO

14221074

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are methods and compositions for modifying TCR genes, using nucleases (zinc finger nucleases or TAL nucleases) to modify TCR genes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANGAMO THERAPEUTICS INC7000 MARINA BOULEVARD BRISBANE CA 94005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bonini, Maria Chiara Milan, IT 15 353
Genovese, Pietro Milan, IT 13 359
Gregory, Philip D Richmond, US 75 3071
Holmes, Michael C Richmond, US 87 3629
Magnani, Zulma Milan, IT 2 108
Mastaglio, Sara Milan, IT 2 108
Naldini, Luigi Milan, IT 49 1055
Paschon, David Richmond, US 62 1913
Zhang, Lei Richmond, US 2499 17879

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 10, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 10, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00